DPP4 and neoplasm: This humanized anti-CD26 mAb YS110, that binds to the cell membrane-proximal glycosylated region starting at the 20-amino acid flexible stalk region of human CD26, has showed anti-tumor effects in malignant mesothelioma (MM) models [4].